See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516551_2019_Skye_Bioscience_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001516551, Skye Bioscience Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,953,687 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,445 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 15,938,971 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,580,413 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,846,283 |
| 9 | ResearchAndDevelopmentExpense | 329,107 |
| 10 | remainder_Expenses | 42,287,069 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 136,281 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,957,132 |
| 1 | Liabilities | 17,519,384 |
| 2 | Expenses | 47,462,459 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -15,562,252 |
| 5 | NetIncome | -47,326,178 |
| 6 | ComprehensiveNetIncome | -47,326,178 |
| 7 | BaseVar | 33,537,628 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -8.34 |
| 9 | EconomicCapitalRatio | 0.00538 |
Edgar->Model Mapping
Feature Distribution
Change over Time
